Level Four Advisory Services’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53M Sell
15,158
-165
-1% -$17.1K 0.04% 358
2026
Q1
$1.48M Buy
15,323
+4,484
+41% +$460K 0.05% 344
2025
Q4
$1.15M Sell
10,839
-174
-2% -$20.2K 0.04% 383
2025
Q3
$1.4M Buy
11,013
+983
+10% +$117K 0.05% 335
2025
Q2
$1.23M Buy
10,030
+249
+3% +$28.4K 0.05% 345
2025
Q1
$991K Sell
9,781
-1,019
-9% -$99.5K 0.04% 348
2024
Q4
$997K Buy
10,800
+1,806
+20% +$177K 0.04% 347
2024
Q3
$895K Buy
8,994
+1,287
+17% +$116K 0.04% 386
2024
Q2
$661K Buy
+7,707
New +$647K 0.03% 421
2023
Q4
Sell
-6,873
Closed -$462K 799
2023
Q3
$462K Buy
+6,873
New +$473K 0.03% 462

Other funds holding EHC

Level Four Advisory Services's EHC Position: Q2 2026 in Review

Level Four Advisory Services reduced its Encompass Health (EHC) stake by 1.1% in Q2 2026, selling an estimated $17.1K and leaving 15,158 shares worth $1.53M. The position accounts for 0.04% of the portfolio, ranked #358.

Level Four Advisory Services first reported a position in EHC in Q3 2023 and has held it in 10 quarters since. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Level Four Advisory Services held 15,158 shares of Encompass Health worth $1.53M as of Q2 2026.
  • Level Four Advisory Services sold 165 Encompass Health shares in Q2 2026, an estimated $17.1K.
  • Encompass Health made up 0.04% of Level Four Advisory Services's portfolio in Q2 2026, its #358 holding.
  • Level Four Advisory Services first reported a position in Encompass Health in Q3 2023 and has held it in 10 quarters since.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.